Addison's disease epidemiology and demographics: Difference between revisions
Aditya Ganti (talk | contribs) |
|||
| (3 intermediate revisions by 2 users not shown) | |||
| Line 4: | Line 4: | ||
{{CMG}} ; {{AE}} {{ADG}} | {{CMG}} ; {{AE}} {{ADG}} | ||
==Overview== | ==Overview== | ||
The prevalence of Addison's disease in the human population is estimated to be roughly 4-12 | The [[prevalence]] of Addison's disease in the human population is estimated to be roughly 4-12 persons per 100,000 persons. The [[incidence]] of Addison's disease is approximately 0.6 per 100,000 individuals worldwide. Addison's disease can affect any age range. Addison's disease occurs more frequently in females as compared to males with a ratio of 12.3 to 1. | ||
==Epidemiology == | ==Epidemiology == | ||
| Line 10: | Line 10: | ||
The [[prevalence]] of Addison's disease in the human population is sometimes estimated at roughly 4-12 people per 100,000 persons. | The [[prevalence]] of Addison's disease in the human population is sometimes estimated at roughly 4-12 people per 100,000 persons. | ||
===Incidence=== | ===Incidence=== | ||
The incidence Addison's disease is approximately 0.6 per 100,000 individuals worldwide. | The [[incidence]] Addison's disease is approximately 0.6 per 100,000 individuals worldwide. | ||
==Demographics== | ==Demographics== | ||
===Age=== | ===Age=== | ||
*Addison disease can affect any age range. | *Addison disease can affect any age range. | ||
*Addison's disease typically presents in adults between 30 and 50 years of age as most are often diagnosed with autoimmune-associated diseases.<ref name="pmid20176260">{{cite journal |vauthors=Michels AW, Eisenbarth GS |title=Immunologic endocrine disorders |journal=J. Allergy Clin. Immunol. |volume=125 |issue=2 Suppl 2 |pages=S226–37 |year=2010 |pmid=20176260 |pmc=2835296 |doi=10.1016/j.jaci.2009.09.053 |url=}}</ref> | *Addison's disease typically presents in adults between 30 and 50 years of age as most are often diagnosed with [[Autoimmune diseases|autoimmune-associated diseases]].<ref name="pmid20176260">{{cite journal |vauthors=Michels AW, Eisenbarth GS |title=Immunologic endocrine disorders |journal=J. Allergy Clin. Immunol. |volume=125 |issue=2 Suppl 2 |pages=S226–37 |year=2010 |pmid=20176260 |pmc=2835296 |doi=10.1016/j.jaci.2009.09.053 |url=}}</ref> | ||
===Gender=== | ===Gender=== | ||
Addison's disease occur more frequently in females | Addison's disease occur more frequently in females as compared to males with a ratio of 12.3 to 1. <ref name="pmid9281381">{{cite journal| author=Jacobson DL, Gange SJ, Rose NR, Graham NM| title=Epidemiology and estimated population burden of selected autoimmune diseases in the United States. | journal=Clin Immunol Immunopathol | year= 1997 | volume= 84 | issue= 3 | pages= 223-43 | pmid=9281381 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=9281381 }} </ref> | ||
===Race=== | ===Race=== | ||
There is no racial predilection to Addison's disease. | There is no racial predilection to Addison's disease. | ||
===Geographical distrubution=== | ===Geographical distrubution=== | ||
Addison's disease may be more common in areas where systemic fungal infections such as [[histoplasmosis]] can cause destruction of the adrenal cortex by disseminated infection or secondary to antifungal medications. | Addison's disease may be more common in areas where systemic fungal infections such as [[histoplasmosis]] can cause destruction of the [[adrenal cortex]] by disseminated infection or secondary to [[antifungal]] medications. | ||
==References== | ==References== | ||
Latest revision as of 20:24, 11 October 2017
|
Addison's disease Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Addison's disease epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Addison's disease epidemiology and demographics |
|
Risk calculators and risk factors for Addison's disease epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] ; Associate Editor(s)-in-Chief: Aditya Ganti M.B.B.S. [2]
Overview
The prevalence of Addison's disease in the human population is estimated to be roughly 4-12 persons per 100,000 persons. The incidence of Addison's disease is approximately 0.6 per 100,000 individuals worldwide. Addison's disease can affect any age range. Addison's disease occurs more frequently in females as compared to males with a ratio of 12.3 to 1.
Epidemiology
Prevalence
The prevalence of Addison's disease in the human population is sometimes estimated at roughly 4-12 people per 100,000 persons.
Incidence
The incidence Addison's disease is approximately 0.6 per 100,000 individuals worldwide.
Demographics
Age
- Addison disease can affect any age range.
- Addison's disease typically presents in adults between 30 and 50 years of age as most are often diagnosed with autoimmune-associated diseases.[1]
Gender
Addison's disease occur more frequently in females as compared to males with a ratio of 12.3 to 1. [2]
Race
There is no racial predilection to Addison's disease.
Geographical distrubution
Addison's disease may be more common in areas where systemic fungal infections such as histoplasmosis can cause destruction of the adrenal cortex by disseminated infection or secondary to antifungal medications.
References
- ↑ Michels AW, Eisenbarth GS (2010). "Immunologic endocrine disorders". J. Allergy Clin. Immunol. 125 (2 Suppl 2): S226–37. doi:10.1016/j.jaci.2009.09.053. PMC 2835296. PMID 20176260.
- ↑ Jacobson DL, Gange SJ, Rose NR, Graham NM (1997). "Epidemiology and estimated population burden of selected autoimmune diseases in the United States". Clin Immunol Immunopathol. 84 (3): 223–43. PMID 9281381.